The clerk called the case, and four federal judges answered. That is the first thing an outsider notices about the Camp Lejeune docket. Not one judge on the bench, but a panel of four, assembled because a single Article III jurist could not physically absorb what Congress had dropped on the Eastern District of North Carolina in the summer of 2022.<\/p>\n
Chief Judge Richard E. Myers II. Senior Judge Terrence W. Boyle. Judge Louise W. Flanagan. Judge James C. Dever III. Between them they cover a district that runs from the Outer Banks to the tobacco country west of Raleigh, and for the better part of three years they have been running, jointly, the largest single-event tort program in the modern history of the federal courts.<\/p>\n
The subject is water. Water that ran through the taps at Marine Corps Base Camp Lejeune from 1953 until 1987, drawn from the Tarawa Terrace and Hadnot Point treatment plants, laced with trichloroethylene, tetrachloroethylene, benzene, and vinyl chloride at concentrations that Agency for Toxic Substances and Disease Registry scientists would later measure in the hundreds and thousands of parts per billion. Marines drank it. Their spouses cooked with it. Their children bathed in it. And for decades, when those people got sick, they had no way to sue, because the federal government sat behind sovereign immunity and North Carolina’s statute of repose sealed the door from the other side.<\/p>\n
Then Congress opened the door. All the way.<\/p>\n
The Camp Lejeune Justice Act of 2022 arrived folded inside a much larger veterans bill, the Honoring our PACT Act of 2022, Pub. L. No. 117-168, which President Biden signed on August 10, 2022. The relevant language is short. Any person, including a veteran, who was exposed to the contaminated water for at least thirty days between August 1953 and December 1987, and who suffered harm as a result, could bring an action. The statute set the burden of causation low, at the ATSDR-friendly standard of a relationship that is either sufficient to conclude causation or at least as likely as not. It stripped the government of most of its usual immunity defenses. And it funneled every one of these cases into a single forum: the United States District Court for the Eastern District of North Carolina, and nowhere else.<\/p>\n
Two years. That was the window. File within two years of enactment, and first exhaust an administrative claim with the Department of the Navy, whose Tort Claims Unit in Norfolk sat six months on each submission before a claimant could sue. Do the arithmetic and the practical cutoff for lawsuits landed on August 10, 2024, with the administrative filings needing to precede that by the statutory six months.<\/p>\n
What came through the door was staggering.<\/p>\n
By the two-year mark, the Navy had logged more than 500,000 administrative claims. Read that number again. More than half a million people, or their estates, told the United States government that Camp Lejeune’s water had killed or sickened them or someone they loved. On the litigation side, the count of filed lawsuits climbed past 2,000 and kept climbing, each one consolidated into the master proceeding the court styled In re Camp Lejeune Water Litigation<\/em>, No. 7:23-cv-897 (E.D.N.C.).<\/p>\n The Congressional Budget Office had guessed, before enactment, that the whole program might cost the Treasury somewhere around $6.1 billion over a decade. Plaintiffs’ lawyers laughed at that figure in private and said so in public. A liability universe of half a million claimants, many with cancers that carry six- and seven-figure valuations, does not settle for six billion dollars. Everyone in the courtroom knew it. The only open question was how the machine built to process those claims would actually run.<\/p>\n The judges moved to build it. They entered a series of case management orders, appointed a Plaintiffs’ Leadership Group, and named J. Edward Bell III of the Bell Legal Group as Lead Counsel for the plaintiffs, a South Carolina trial lawyer who had spent a good part of his career on exactly this kind of grinding mass litigation. The government came to the table with the Environmental Torts Litigation Section of the Department of Justice, backed by Navy lawyers who understood, better than anyone, just how thin the government’s factual defenses had become once Congress rewrote the causation rules.<\/p>\n The pieces were in place. Then the noise started.<\/p>\n If you owned a television in 2023 and watched anything with a commercial break, you saw it. The grainy stock footage of a base gate. The somber voice. The 1-800 number. The words on the screen, in bold: if you or a loved one lived or worked at Camp Lejeune between 1953 and 1987, you may be entitled to significant compensation.<\/p>\n It was, by the measure of the firms that track this sort of thing, the most heavily advertised legal matter the country had ever produced. Ad-tracking analysts at X Ante and others reported that Camp Lejeune spots aired hundreds of thousands of times across a single year, saturating daytime cable, late-night broadcast, and the digital feeds where the older veterans who mattered most to the plaintiffs’ bar actually spent their time. A Camp Lejeune ad ran during the Super Bowl. Estimates of the total legal-marketing spend on the campaign climbed into the hundreds of millions of dollars, with some observers putting the all-in figure, across every channel and every lead generator, near or above a billion.<\/p>\n Think about what that money was buying. It was not, mostly, buying the services of the trial lawyers who would one day stand in front of Judge Myers. It was buying names. Leads. Signed retainer agreements, harvested by call centers and marketing outfits and then sold, or referred for a cut, up a chain that ended at the firms with the capital to actually prosecute the claims. A single qualified Camp Lejeune lead, at the peak of the frenzy, traded for a price that would have made a personal-injury lawyer of an earlier generation choke on his coffee.<\/p>\n The volume created its own problems, and the problems reached Washington. Senators from both parties, watching the ad barrage and doing the math on contingency fees against a taxpayer-funded liability, started talking about capping what the lawyers could take. The truth, buried under the political noise, was that a cap already existed. Because Camp Lejeune claims travel on the chassis of the Federal Tort Claims Act, the fee limits of 28 U.S.C. 2678 apply: twenty percent of an administrative settlement, twenty-five percent of a judgment or a settlement reached after suit. Those are hard ceilings, and a lawyer who charges more commits a crime under the statute.<\/p>\n Twenty and twenty-five percent sounds modest until you multiply it across a book of thousands of claims worth a few hundred thousand dollars apiece. Then it sounds like an industry. And an industry is what assembled itself, almost overnight, around a water system in Onslow County that had stopped poisoning anyone in 1987.<\/p>\n The government, to its credit, understood early that it could not litigate half a million claims one at a time. So in September 2023 the Department of Justice and the Navy rolled out what they called the Elective Option, a voluntary, tiered settlement framework meant to clear the simplest and strongest cases without discovery, depositions, or trial.<\/p>\n The design was clean. Claimants with certain diseases that the science most closely tied to the contaminants, and with documented exposure of a qualifying length, could take a fixed payment scaled to two variables: which disease, and how long the exposure lasted. The framework sorted the qualifying illnesses into tiers. Tier 1 held the cancers with the strongest epidemiological link, kidney cancer, bladder cancer, leukemia, non-Hodgkin lymphoma, and Parkinson’s disease among them. Tier 2 held conditions with a somewhat weaker but still recognized association.<\/p>\n The dollars ran, roughly, from $150,000 at the low end for shorter exposures and lower-tier illnesses up to $450,000 for the longest exposures and the most strongly linked diseases, with an additional payment, on the order of $100,000, layered on where the claimant had died. A claimant could accept the number, sign, and be done. No jury. No decade of appeals. No fight over whether benzene at a given concentration caused a given leukemia.<\/p>\n On paper it was elegant. In practice it moved like cold honey.<\/p>\n The problem was throughput. The Navy’s claims unit and the DOJ were trying to verify exposure and diagnosis for an inventory measured in the hundreds of thousands, and the verification took time the claimants did not have, because a great many of them were old, and sick, and dying while their files sat in a queue. Through the back half of 2023 and into 2024, plaintiffs’ lawyers grew loud about the pace. They pointed to a program that had received well over half a million claims and had actually paid, in its opening stretch, a number of settlements that looked like a rounding error against that inventory. Reporting from Reuters and Bloomberg Law through 2024 tracked a payout total that lagged far, far behind the claim count, with the government offering and paying in the low hundreds of millions while the theoretical liability sat in the tens of billions.<\/p>\n Bell and the leadership group kept pressing, in filings and in status conferences, for the government to widen the Elective Option, speed the verifications, and add diseases. The government kept answering that it was scaling up, hiring, and processing as fast as due diligence on public money allowed. Both things were true at once. The framework was a genuine attempt to do mass justice at scale, and it was nowhere near fast enough for people running out of time.<\/p>\n Meanwhile a second track, the litigation track, ground forward for everyone who would not or could not take the elective number.<\/p>\n You cannot try 2,000 cases. You cannot try 200. What a court in this position does, and what the Camp Lejeune panel did, is pick a small representative set, litigate those to the point of trial, and let the results teach both sides what the rest of the inventory is worth.<\/p>\n The judges organized the litigation around illness. Through their case management orders, they carved out an initial group of Track 1 diseases, five conditions with the strongest scientific footing, bladder cancer, kidney cancer, leukemia, non-Hodgkin lymphoma, and Parkinson’s disease, and set discovery marching toward a slate of bellwether trials. The parties traded plaintiff pools, argued over sampling, deposed the treating physicians, and lined up the epidemiologists and hydrologists and toxicologists whose testimony would decide whether a particular plume, at a particular tap, in a particular year, could have caused a particular tumor.<\/p>\n And then they fought, hard, over a question that most tort lawyers never have to think about: was there a jury at the end of this at all?<\/p>\n The Camp Lejeune Justice Act says nothing about juries. Congress wrote a cause of action, set a causation standard, named a court, and went home. Into that silence the two sides poured very different readings of history and text. The plaintiffs argued that the Act created a new, freestanding cause of action sounding in the kind of common-law damages claim that the Seventh Amendment has protected since 1791, and that the men and women of eastern North Carolina were entitled to have their neighbors, in a jury box, decide what the water had done to them.<\/p>\n The government argued the opposite, and it argued from the plumbing. Camp Lejeune claims, DOJ said, are claims against the United States, waivers of sovereign immunity, and suits against the sovereign are tried to the bench unless Congress clearly says otherwise. The government pointed to 28 U.S.C. 2402 and to the FTCA tradition of judge trials, and it insisted that Congress, having built the CLJA on the FTCA framework, had imported that tradition along with everything else.<\/p>\n The four judges took the question up together, and in 2024 they resolved it in the government’s favor. There would be no jury. The Camp Lejeune cases would be tried to the bench, decided by the same panel of four that had been managing the docket all along. For the plaintiffs’ bar it was a real blow, and a strategic one. A jury of local citizens, many of whom knew someone with a Camp Lejeune story, was worth a great deal of settlement leverage. A cool federal judge weighing hydrogeology and Kaplan-Meier survival curves is a different audience, and a harder one, and everyone knew it.<\/p>\n The ruling reshaped the negotiation. Strip out the runaway-verdict risk and you strip out a chunk of the pressure that drives a defendant to overpay. The government’s hand strengthened. The plaintiffs’ pivot, then, was toward volume and toward the bellwethers, betting that a bench that heard the real medical proof, on the strongest diseases, would return numbers high enough to reprice the whole inventory upward and force the Elective Option to follow.<\/p>\n Through 2025 the docket lived in that tension. Discovery deadlines slipped and reset. The court leaned on special masters and settlement facilitation to move the mountain. Trial settings on the Track 1 cases inched forward against a backdrop of expert disputes and the plain difficulty of proving, to a demanding standard, causation for illnesses that surface twenty, thirty, forty years after the exposure that a claimant says produced them. The machine ran. It ran slowly. And every month it ran, more of the people whose names filled those 500,000 files died waiting.<\/p>\n Step back from New Bern and Raleigh and look at what a program like this does to the plaintiffs’ bar itself, because that is the part that outlasts the litigation.<\/p>\n A mega-claim program rewires the economics of a law firm. The old model of the plaintiff’s attorney, a lawyer who knows a client, works a file, tries a case, is almost entirely absent from the front end of Camp Lejeune. In its place sits a supply chain. Marketing companies at the top, spending the ad dollars and capturing the leads. Intake shops and referral networks in the middle, packaging signed claimants into inventory. And at the bottom, the firms with the balance sheets to carry thousands of cases for years without a dime of return, financing the whole operation, increasingly, with outside litigation capital that expects a venture-style multiple on the back end.<\/p>\n That structure produces things the profession should watch closely. It produces clients who have never spoken to the lawyer whose name is on their retainer. It produces books of business bought and sold like commodities. It produces the grim spectacle, which the Camp Lejeune program generated in real quantity, of firms that signed thousands of claimants and then lacked the capacity to actually service them, so that people who answered a television ad in 2023 could not get a human being on the phone in 2025.<\/p>\n It produces something else, too, a barrier to entry that reshapes who gets to do this work. When the price of a competitive claim book runs into the millions of dollars of ad spend and case financing, the small firm and the solo practitioner are locked out of the front door. The work concentrates. A handful of large operations, and the funders standing behind them, come to control access to an entire category of injured people. Whether that concentration serves the clients or the firms is a question the fee arithmetic answers uncomfortably.<\/p>\n The lawyers who make the leadership group, by contrast, do genuinely hard and genuinely valuable work. Someone has to build the causation science, argue the jury question, structure the bellwethers, and negotiate the framework that resolves cases the individual claimant could never have resolved alone. Bell’s group and the DOJ lawyers across from them were doing legitimate mass-tort engineering, the kind that has resolved asbestos and tobacco and opioid liability when nothing else could. The problem was never the courtroom. The problem was the funnel that fed the courtroom, and the distance that funnel opened between the injured person and the lawyer who was supposed to represent them.<\/p>\n Here is where I will take the leash off.<\/p>\n The Camp Lejeune Justice Act was a genuine act of moral repair. Congress looked at people the government had poisoned and then blocked from any remedy for forty years, and it opened a path to compensation. That was right. I have no quarrel with the statute, and I have less than none with the veterans and families it was written to help.<\/p>\n My quarrel is with what we let grow in the space between the statute and those families. We built a remedy and then handed its front end to an advertising market that treated dying Marines as inventory, priced their signatures, and pocketed the spread. We stood up a settlement framework, the Elective Option, that was decent in design and glacial in execution, and we watched it pay a fraction of its inventory while claimants aged out of the process the only way a person can age out of it. We resolved the jury question in a way that was probably correct as a matter of law and that quietly drained the leverage the sickest plaintiffs had left. And through all of it, the fee ceilings of Section 2678, meant to protect claimants, sat like a floor that the whole industry organized itself to reach.<\/p>\n The four judges of the Eastern District of North Carolina did not ask for any of this. They inherited a caseload no district was built to hold, and they have managed it with more discipline and less drama than the numbers had any right to expect. If there is a heroic institution in this story, it is that small panel and its overworked clerks, processing a national reckoning out of courthouses in New Bern and Raleigh.<\/p>\n But the model itself, the mega-claim machine that Camp Lejeune perfected, is going to keep coming. The next contaminant, the next drug, the next device will draw the same ad wave, the same lead brokers, the same funded roll-up of human suffering into tradeable case files. Camp Lejeune is the template now. What it proved is that we can process half a million injuries through a single federal district. What it has not yet proved, four years and hundreds of thousands of unresolved claims later, is that we can do it fast enough, or cleanly enough, to reach the people before the water finally finishes what it started.<\/p>\n","protected":false},"excerpt":{"rendered":" Half a million claims, one small federal district, and a settlement engine still sputtering. A look at how the Camp Lejeune Justice Act reshaped plaintiff-side practice through 2025.<\/p>\n","protected":false},"author":1,"featured_media":71,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15],"tags":[],"class_list":["post-25","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-courts-cases"],"yoast_head":"\nthe ad wave nobody could turn off<\/h2>\n
the elective option and the arithmetic of a settlement<\/h2>\n
tracks, bellwethers, and the fight over the jury box<\/h2>\n
what the machine does to the lawyers who feed it<\/h2>\n
a verdict on the process, if not the cases<\/h2>\n